These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 14330876)

  • 21. Continuous flow technology vs. the batch-by-batch approach to produce pharmaceutical compounds.
    Cole KP; Johnson MD
    Expert Rev Clin Pharmacol; 2018 Jan; 11(1):5-13. PubMed ID: 29206489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [REMARKS ON "INSTRUCTION ON THE DUTY OF THE STAATLICHE INSTITUT FUER ARZNEIMITTELPRUEFUNG"].
    PAAPE W
    Pharm Prax; 1963; 19():168-9. PubMed ID: 14203599
    [No Abstract]   [Full Text] [Related]  

  • 23. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD
    Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [ON ELECTRIZATION IN THE PREPARATION OF TABLET FORMS OF DRUG PREPARATIONS].
    MAKHKAMOV SM
    Med Prom SSSR; 1963 Nov; 17():42-5. PubMed ID: 14134144
    [No Abstract]   [Full Text] [Related]  

  • 25. Formulation of a parenteral antimalarial solution--a French undergraduate project in industrial pharmacy.
    Jeannin C; Pourcelot Y
    Am J Pharm Educ; 1977 Feb; 41(1):59-61. PubMed ID: 10236632
    [No Abstract]   [Full Text] [Related]  

  • 26. [ON THE DEVELOPMENT OF SCIENTIFIC RESEARCH FOR INCREASED PRODUCTION OF COMBINED DRUG PREPARATIONS].
    KUDRIN AN; MELNICHENKO AK
    Aptechn Delo; 1963; 12():14-7. PubMed ID: 14082752
    [No Abstract]   [Full Text] [Related]  

  • 27. [THE SILICONES AND THEIR APPLICATIONS IN PHARMACY].
    GANCBERG A
    J Pharm Belg; 1963; 18():321-38. PubMed ID: 14067932
    [No Abstract]   [Full Text] [Related]  

  • 28. [DATA FROM THE WORK OF THE STAATLICHE INSTITUTFU MITTELPRUEFUNG, BERLIN. 7. THE NEW DUTY OF THE STAATLICH INSTITUT FUER ARZNEIMITTELPRUEFUNG, BERLIN FROM 1963].
    NEUHAUS HJ
    Pharm Prax; 1963; 19():171-3. PubMed ID: 14203601
    [No Abstract]   [Full Text] [Related]  

  • 29. Basics of sterile compounding: aseptic processing.
    Akers MJ
    Int J Pharm Compd; 2015; 19(1):49-56. PubMed ID: 25902628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The texture and properties of acetylsalicylic acid tablets. 1. The effect of manufacturing methods on the properties of tablets].
    Nagy G; Keresztes A; Pintye-Hódi K; Selmeczi B; Kedvessy G
    Pharmazie; 1978 Nov; 33(11):747-9. PubMed ID: 751075
    [No Abstract]   [Full Text] [Related]  

  • 31. REGULATION governing the establishment and operation of pharmaceutical drug, and/or biological manufacturing laboratories, and the distribution and sale of pharmaceutical and biologic products.
    J Philipp Med Assoc; 1953 Feb; 29(2):74-82. PubMed ID: 13035712
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessing risks of changing sterile drug manufacturing sites.
    Langille SE; Campbell C
    PDA J Pharm Sci Technol; 2010; 64(1):3-10. PubMed ID: 21501998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding.
    Ligugnana R
    Int J Pharm Compd; 2017; 21(3):182-190. PubMed ID: 28557779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [GENERAL MANUFACTURE OF DRUGS AND TECHNICAL STANDARDS].
    HEINIGE A
    Cesk Farm; 1964 Nov; 13():474-5. PubMed ID: 14261159
    [No Abstract]   [Full Text] [Related]  

  • 35. Development of parenteral and sterile ophthalmic suspensions--the R & D approach.
    Portnoff JB; Cohen EM; Henley MW
    Bull Parenter Drug Assoc; 1977; 31(3):136-43. PubMed ID: 880416
    [No Abstract]   [Full Text] [Related]  

  • 36. A proposal for a drug product Manufacturing Classification System (MCS) for oral solid dosage forms.
    Leane M; Pitt K; Reynolds G;
    Pharm Dev Technol; 2015 Jan; 20(1):12-21. PubMed ID: 25162770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Component Selection for Sterile Compounding.
    Dilzer RH
    Int J Pharm Compd; 2017; 21(4):277-280. PubMed ID: 28719369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overview of "The Study in Risk-Based Manufacturing Environmental Control for Non-Sterile Drug Products".
    Shirokizawa O; Inoue K; Kamikukita T
    PDA J Pharm Sci Technol; 2021; 75(6):490-505. PubMed ID: 33990419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing Patient Safety by Closing the Sterile Production Gap-Part 3-Moist Heat Resistance of Bioburden.
    Agalloco JP
    PDA J Pharm Sci Technol; 2017; 71(4):274-278. PubMed ID: 28416646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sterile Basics of Compounding: Methods of Sterilization and Depyrogenation.
    Allen LV
    Int J Pharm Compd; 2022; 26(2):129-136. PubMed ID: 35413012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.